| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T308 |
0-3 |
Sentence |
denotes |
14. |
| T309 |
4-15 |
Sentence |
denotes |
Conclusions |
| T310 |
16-224 |
Sentence |
denotes |
There is limited knowledge regarding coronavirus infections that occur during pregnancy—what is known has, for the most part, been the result of epidemics resulting from two different diseases, SARS and MERS. |
| T311 |
225-498 |
Sentence |
denotes |
These previous experiences with coronavirus infections in pregnancy indicates that these agents are capable of causing adverse clinical outcomes including life-threatening maternal disease that in some cases requires hospitalization, intensive care and ventilatory support. |
| T312 |
499-691 |
Sentence |
denotes |
Both of these coronaviruses can result in maternal death in a small but significant number of cases, but the specific risk factors for a fatal outcome during pregnancy have not been clarified. |
| T313 |
692-891 |
Sentence |
denotes |
Coronaviruses can also result in adverse outcomes for the fetus and infant including intrauterine growth restriction, preterm delivery, admission to the ICU, spontaneous abortion and perinatal death. |
| T314 |
892-1147 |
Sentence |
denotes |
Unlike some viral infections, notably Ebola virus [70] and Zika virus [80], the likelihood of intrauterine maternal-fetal transmission of coronaviruses is low—there have been no documented cases of vertical transmission occurring with either SARS or MERS. |
| T315 |
1148-1614 |
Sentence |
denotes |
It remains to be seen during the current Wuhan 2019-nCoV epidemic how this newly-emergent coronavirus affects pregnant women and their infants, as well as which factors may modulate obstetrical disease and outcomes including the timing of maternal coronavirus exposure by gestational age, the effects of medications or other treatment regimens, differences in host immune responses, occurrence of coexisting medical and obstetrical conditions, and other covariables. |
| T316 |
1615-1753 |
Sentence |
denotes |
However, pregnant women should be considered to be at high risk for developing severe infection during this current outbreak of 2019-nCoV. |
| T317 |
1754-1968 |
Sentence |
denotes |
Additional clinical research on the treatment of SARS, MERS, and the new coronavirus 2019-nCoV is necessary if we are to understand the potential risks and benefits of novel therapies and new vaccines in pregnancy. |
| T318 |
1969-2111 |
Sentence |
denotes |
This research will be critical in improving the care, and even saving the lives, of pregnant women in the current as well as future outbreaks. |
